| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1011685759 |
| P356 | DOI | 10.1186/1868-7083-5-2 |
| P932 | PMC publication ID | 3599401 |
| P698 | PubMed publication ID | 23324568 |
| P5875 | ResearchGate publication ID | 234157185 |
| P50 | author | Tom Van Wezel | Q42794317 |
| Arnoud Boot | Q52720615 | ||
| P2093 | author name string | Judith M Boer | |
| Hans Morreau | |||
| Ashwin A Dihal | |||
| Eddy H van Roon | |||
| Robert F Ernst | |||
| P2860 | cites work | Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification. | Q37988465 |
| Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells | Q39840959 | ||
| Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis | Q40147027 | ||
| Methylation patterns of IGFBP7 in colon cancer cell lines are associated with levels of gene expression | Q40163915 | ||
| Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. | Q41650479 | ||
| Activation of forkhead box O transcription factors by oncogenic BRAF promotes p21cip1-dependent senescence. | Q41680604 | ||
| Adaptable gene-specific dye bias correction for two-channel DNA microarrays | Q42145024 | ||
| BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis? | Q42947711 | ||
| Histone H3 lysine 27 trimethylation in adult differentiated colon associated to cancer DNA hypermethylation | Q46092830 | ||
| Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer | Q46578998 | ||
| Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays | Q51602472 | ||
| High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines. | Q54761360 | ||
| Microsatellite instability in colorectal cancer | Q24627393 | ||
| The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores | Q24649374 | ||
| CpG island methylator phenotype in colorectal cancer | Q24672170 | ||
| Expression analysis of candidate breast tumour suppressor genes on chromosome 16q | Q25257454 | ||
| Control of developmental regulators by Polycomb in human embryonic stem cells | Q28235841 | ||
| Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum | Q28262150 | ||
| Microsatellite instability and MLH1 promoter hypermethylation in colorectal cancer | Q28299711 | ||
| PANTHER: a library of protein families and subfamilies indexed by function | Q29547480 | ||
| CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer | Q29614277 | ||
| Mechanisms of polycomb gene silencing: knowns and unknowns | Q29614511 | ||
| MethPrimer: designing primers for methylation PCRs | Q29618664 | ||
| Epigenetic stem cell signature in cancer | Q29622897 | ||
| Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer | Q29622925 | ||
| Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates | Q30942652 | ||
| limmaGUI: a graphical user interface for linear modeling of microarray data | Q33205531 | ||
| A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing | Q33268624 | ||
| Analysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profiling | Q33520213 | ||
| Unlocking the secrets of the genome | Q33745487 | ||
| FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells | Q33767083 | ||
| Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition? | Q33892398 | ||
| Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer | Q33892868 | ||
| Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer | Q34018681 | ||
| COBRA: a sensitive and quantitative DNA methylation assay | Q34630070 | ||
| FOXA1 in breast cancer | Q34956469 | ||
| BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum | Q35596687 | ||
| A predicted hairpin cluster correlates with barriers to PCR, sequencing and possibly BAC recombineering | Q35664951 | ||
| Colorectal cancer: a tale of two sides or a continuum? | Q35935945 | ||
| Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. | Q36276940 | ||
| Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer | Q36891683 | ||
| Epigenetic cross-talk between DNA methylation and histone modifications in human cancers | Q37314994 | ||
| Epigenomics of human colon cancer. | Q37778473 | ||
| P4510 | describes a project that uses | limma | Q112236343 |
| P433 | issue | 1 | |
| P921 | main subject | colorectal cancer | Q188874 |
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 2 | |
| P577 | publication date | 2013-01-16 | |
| P1433 | published in | Clinical Epigenetics | Q18620113 |
| P1476 | title | BRAF mutation-specific promoter methylation of FOX genes in colorectal cancer | |
| P478 | volume | 5 |
| Q64059376 | Allelic Switching of , , and during Colorectal Cancer Tumorigenesis |
| Q42353442 | BRAF inhibitor treatment of melanoma causing colonic polyps: An alternative hypothesis |
| Q38792685 | Characterization of novel low passage primary and metastatic colorectal cancer cell lines |
| Q36849645 | Colorectal cancer carcinogenesis: a review of mechanisms |
| Q35584026 | Coordinated epigenetic remodelling of transcriptional networks occurs during early breast carcinogenesis. |
| Q92069595 | Critical physiological and pathological functions of Forkhead Box O tumor suppressors |
| Q33617915 | DNA methylation characteristics of primary melanomas with distinct biological behaviour. |
| Q35642026 | Decreased FOXD3 Expression Is Associated with Poor Prognosis in Patients with High-Grade Gliomas |
| Q42454854 | Epigenetic alterations in sporadic basal cell carcinomas. |
| Q26823070 | Epigenetic modifications in colorectal cancer: molecular insights and therapeutic challenges |
| Q41532605 | Evidence for genetic association between chromosome 1q loci and predisposition to colorectal neoplasia |
| Q38603133 | FOXD3 Regulates CSC Marker, DCLK1-S, and Invasive Potential: Prognostic Implications in Colon Cancer |
| Q92154743 | Identification of differentially expressed genes regulated by methylation in colon cancer based on bioinformatics analysis |
| Q48042328 | Imprinted survival genes preclude loss of heterozygosity of chromosome 7 in cancer cells. |
| Q41911913 | Methylation associated transcriptional repression of ELOVL5 in novel colorectal cancer cell lines |
| Q97643297 | Non-invasive early detection of cancer four years before conventional diagnosis using a blood test |
| Q38733079 | The FOXD3/miR-214/MED19 axis suppresses tumour growth and metastasis in human colorectal cancer |
| Q37288532 | The homeobox gene MEIS1 is methylated in BRAF (p.V600E) mutated colon tumors |
| Q37631429 | Tumor LINE-1 Methylation Level in Association with Survival of Patients with Stage II Colon Cancer. |
| Q38190872 | Tumor cell plasticity: the challenge to catch a moving target |
Search more.